Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 241 to 250

RITHMIK amiodarone hydrochloride 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
EZETIMIBE/ATORVASTATIN SANDOZ 10/10, EZETIMIBE/ATORVASTATIN SANDOZ 10/20, EZETIMIBE/ATORVASTATIN SANDOZ 10/40, EZETIMIBE/ATORVASTATIN SANDOZ 10/80 (Sandoz Pty Ltd)

21 June 2022

Prescription medicine registration

Active ingredients: Atorvastatin calcium trihydrate, Ezetimibe.
OLMESARTAN/AMLODIPINE SANDOZ (Sandoz Pty Ltd)

21 June 2022

Prescription medicine registration

Active ingredients: Amlodipine besilate, Olmesartan medoxomil.
MENDELEEV PARACETAMOL 500 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

20 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
SANDOZ PARACETAMOL paracetamol 500mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

20 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
PEMETREXED SANDOZ pemetrexed (as disodium) 500mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

8 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MIRTAZAPINE SANDOZ ODT 15 mirtazapine 15 mg orally disintegrating tablets blister pack Cancelled under Section 30(1)(c) of the Act

6 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
CASPOFUNGIN SANDOZ Caspofungin (as acetate) 50mg powder for injection Cancelled under Section 30(1)(c) of the Act

6 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
CASPOFUNGIN SANDOZ Caspofungin (as acetate) 70mg powder for injection Cancelled under Section 30(1)(c) of the Act

6 June 2022

Cancellation by sponsor

Requested by Sandoz Pty Ltd
DASATINIB SANDOZ dasatinib 70 mg film-coated tablet bottle (335110)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DASATINIB SANDOZ dasatinib 70 mg film-coated tablet bottle.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.